Manulife Financial (MFC.TO) Buy, Sell or Hold

Home

Daily Stock Opinions and Ratings

Manulife Financial (MFC.TO)

60.39

-0.28 (0.46%)

as of Jul 23, 2026, 6:04:18 pm Market Open.

1632 watching

Investor Insights

Jul 23, 2026, 12:00 am

This summary was created by AI, based on 27 opinions in the last 12 months.

Manulife Financial (MFC) has received mixed reviews from various experts, highlighting both its strengths and concerns. Many praise the company for its solid performance in Asia and wealth management, coupled with a healthy dividend yield, making it an attractive income stock. However, some analysts express caution due to overvaluation, suggesting that MFC may be overbought, trading at over 2x book value with slow earnings growth of around 8-9%. While the stock is seen as a reasonable long-term holding, there are calls for potential buying opportunities during market pullbacks. The general sentiment reflects a wait-and-see approach given the mixed indicators and the overall health of the financial sector.

Consensus

Cautious

Valuation

Fair Value

Similar

SLF

COMMENT

He finds it is a bit of a black box. He finds it hard to understand their business because there are so many moving parts. The banks are more protected from foreign competition or ownership.

HOLD

They raised the dividend late last year and he expects another boost again. They are growing their business in Asia. Margins have been squeezed a bit with lower interest rates, but based on their recent earnings report, they are weathering it well. He thinks there is value up to $28-$30. Yield 4%

HOLD

The stock is cheap and he holds it in the portfolio. Trades at a low price to book value. Yield 4.5%

COMMENT

This and SLF have been diversifying. MFC is pushing their wealth management business and increasingly from the Asian market. He's gun-shy on MFC. He used to own it.

BUY

Likes the financial sector. It’s been in a tight range. Found support around $22.50. There is good support at $20. Would be a buyer here.

BUY

Average down? Yes, enter it now. MFC trades at 7x earnings and yields over 4% and trades below book value, so it's now at a discount. Their wealth/asset management and Asian business are doing well.

BUY

Long term? He likes MFC, a mainstay for him. MFC has been through a trial over the past 12 months with a legal issue. He likes the 4.6% dividend, which matches the banks, something he was a doubtful about just recently. MFC isn't a bad way to collect yield. It has strong fundamentals. Good long term and he would add to it now. They are growing their dividend.

HOLD

It has been a bit of a disappointment in that it has Asian exposure and has been there for decades, but the yield curve is a real headwind. They have to keep taking charges. He prefers SLF-T. They are good, solid companies, but they need a break on the yield curve.

DON'T BUY

He recently sold it, because MFC broke a trend as interest rates fell and he saw better returns in REITs. MFC's equity division fluctuates with the economy. That said, very long term you can hold this for a long time. But there are better opportunities like the Brookfield REITs.

BUY

Stay in this one. A company you want to hold in a volatile market. Lower interest rates would make this company suffer and this is the fundamental problem for them right now. They need higher rates to fund their actuarial exposure. Buy it here and hold long term. Yield 4.9%

PAST TOP PICK

(A Top Pick Aug 09/18, Down 3%) One of the more diverse names in the insurance space. Exposure to US and Asia. Their results have been fine, and their last quarter was good. You can collect dividends while waiting for the company to get a footing.

DON'T BUY

During low interest rates Low rates are deadly for lifecos which are invested in fixed income and real estate. Don't invest in rate-sensitive stocks.

HOLD

MFC-T vs. Canadian Banks. He considers MFC-T to be a core holding. Low interest rates are a challenge for all financials. MFC-T is cleaning up some assets in the US. They are getting these assets under control. They are still growing in Asia. He thinks low interest rates are priced in to the stock price. (Analysts’ price target is $28.00)

BUY

He sees upside. A large part of the assets are bonds and prices have gone up lately. They are, however, suffering with low yields for new money. New insurance policies should get more expensive. It is a great long term hold and you have to accept the volatility. Things could get softer if rates go to zero.

COMMENT

Great Asian franchise. Problem is the US franchise John Hancock, which dragged down their ROE. Strong asset management in Canada. Nice dividend. Low interest rates not helping. Cleaned up balance sheet. Not paying a lot for the stock.

Showing 361 to 375 of 2,283 entries

Most Recent Experts

Greg Newman

Scotia Wealth Management

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

Jim Cramer - Mad Money

CNBC

John Stephenson

Stephenson & Company Capital Management

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Wealthica The ultimate 360° Tracker Your financial life in one place, automatically

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Manulife Financial (MFC.TO)